NCT06558994 Transection Versus Ligation of Internal Spermatic Vessels in Laparoscopic Fowler-Stephens Orchidopexy
| NCT ID | NCT06558994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Cryptorchidism |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2024-09-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a comparative study to see the outcome of yransection versus ligation of internal spermatic vessels in first stage laparoscopic Fowler-Stephens orchidopexy for intra-abdominal testis in assisting the descent of the testis to the base of scrotum during the second stage
Eligibility Criteria
Inclusion Criteria: All patients with Unilateral or Bilateral impalpable testis Exclusion Criteria: 1. Previous Laparotomy surgery 2. Previous Ventriculo-peritoneal shunt 3. Previous laparoscopy for impalpable testis (outside study) 4. Previous Inguinal/Scrotal surgery 5. Disorder of sexual differentiation 6. Abnormal Karyotyping 7. Intra-operative Inguinal testis 8. Ipsilateral testis : Peeping/ Vas internal internal ring / Vanished / Streak / Ovotestis / Ovary. 9. Contralateral : Streak/ Ovotestis/ Ovary
Contact & Investigator
Mostafa M. Mostafa, MD, MSc, PhD
PRINCIPAL INVESTIGATOR
Assiut University
Frequently Asked Questions
Who can join the NCT06558994 clinical trial?
This trial is open to male participants only, up to 12 Years, studying Cryptorchidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06558994 currently recruiting?
Yes, NCT06558994 is actively recruiting participants. Contact the research team at mostafaabdelaziz91@gmail.com for enrollment information.
Where is the NCT06558994 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06558994 clinical trial?
NCT06558994 is sponsored by Assiut University. The principal investigator is Mostafa M. Mostafa, MD, MSc, PhD at Assiut University. The trial plans to enroll 58 participants.